Table 3.
Outcomes after STEMI
| Total (n=1360) | With HF (n=85) | Without HF (n=1275) | P value | |
| Median follow-up in years (IQR) | 6.7 (2.5–10.9) | 9.4 (6.5–12.6) | 6.4 (0.2–10.8) | <0.001 |
| Revascularisations | ||||
| PCI culprit | 106 (7.8) | 12 (14.1) | 94 (7.4) | 0.025 |
| PCI non-culprit | 117 (8.6) | 10 (11.8) | 107 (8.4) | 0.283 |
| CABG | 77 (5.7) | 9 (10.6) | 68 (5.3) | 0.042 |
| ICD | 83 (6.1) | 38 (44.7) | 45 (3.5) | <0.001 |
| Second MI | 130 (9.6) | 10 (11.8) | 120 (9.4) | 0.475 |
| Stroke | 39 (2.9) | 6 (7.1) | 33 (2.6) | 0.017 |
| Deaths | 162 (11.9) | 20 (23.5) | 142 (11.1) | 0.001 |
Numbers in the columns with and without HF denote n(%), unless specified otherwise.
The P value is derived from the comparison between cases with HF and controls.
CABG, coronary artery bypass grafting; HF, heart failure; ICD, implantable cardioverter-defibrillator; MI, myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.